Annual General Meeting of STRATEC approves increased dividend

Birkenfeld, May 21, 2010

The Annual General Meeting of STRATEC Biomedical Systems AG held on Friday, May 21, 2010, approved all of the agenda items presented for voting with significant majorities in each case.

STRATEC will be distributing a dividend of Euro 0.45 per share (previous year: Euro 0.35) to its shareholders for the 2009 financial year. The distribution per share is thus 29% higher than in the previous year. The dividend will be paid via shareholders’ deposit-holding banks from May 25, 2010.

Furthermore, the Annual General Meeting authorized the Board of Management to acquire and dispose of treasury stock and to amend the Articles of Association to account for the implementation of the Shareholders’ Rights Directive (ARUG).

About STRATEC

STRATEC Biomedical Systems AG (www.stratec-biomedical.de) designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. These partners market such systems, in general together with their own reagents, to laboratories, blood banks and research institutes around the world. The company develops its products on the basis of its own patented technologies. Shares in the company (ISIN: DE0007289001) are traded in the Prime Standard segment of the Frankfurt Stock Exchange.

The STRATEC Group consists of the publicly listed parent company STRATEC Biomedical Systems AG and of subsidiaries and second-tier subsidiaries in Germany, the USA, the UK, Switzerland and Romania.

Further information can be obtained from:

STRATEC Biomedical Systems AG
André Loy, Investor Relations
Gewerbestr. 37, 75217 Birkenfeld
Germany
Phone: +49 7082 7916 190
Fax: +49 7082 7916 999
Email:ir(at)stratec-biomedical.de